表紙
市場調查報告書
商品編碼
1018212

萊姆病診斷的全球市場 - 產業分析,市場規模,佔有率,成長率,趨勢,預測:2021年∼2031年

Lyme Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

出版日期: | 出版商: Transparency Market Research | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球萊姆病診斷市場相關調查分析,過去和目前成長趨勢與機會相關的系統性資訊。

目錄

第1章 序文

第2章 前提條件與調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 主要的產業的發展
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 全球萊姆病診斷市場預測
  • 全球萊姆病診斷市場預測

第5章 市場預測

  • 萊姆病的流行病學
  • 萊姆病相關的法規
  • COVID-19大流行對萊姆病診斷產業的影響
  • 主要的產業的發展

第6章 全球萊姆病診斷市場分析:各診斷檢查

  • 簡介
  • 全球萊姆病診斷市場金額佔有率分析:各診斷檢查
  • 全球萊姆病診斷市場預測:各診斷檢查
    • 血清檢驗
    • 聚合酵素鏈鎖反應(PCR)檢驗
    • 免疫螢光抗體法(IFA)
    • 淋巴球幼少若化檢驗
    • 尿中抗原檢驗
    • 其他
  • 全球萊姆病診斷市場分析:各診斷檢查
  • 全球萊姆病診斷市場魅力分析:各診斷檢查

第7章 全球萊姆病診斷市場分析:各樣品

  • 簡介
  • 全球萊姆病診斷市場金額佔有率分析:各樣品
  • 全球萊姆病診斷市場預測:各樣品
    • 血液
    • 腦脊髓液(CSF)
    • 關節液
    • 尿
  • 全球萊姆病診斷市場分析:各樣品
  • 全球萊姆病診斷市場魅力分析:各樣品

第8章 全球萊姆病診斷市場分析:各終端用戶

  • 簡介
  • 全球萊姆病診斷市場金額佔有率分析:各終端用戶
  • 全球萊姆病診斷市場預測:各終端用戶
    • 醫院
    • 臨床檢驗室
    • 醫生診所
    • 其他
  • 全球萊姆病診斷市場分析:各終端用戶
  • 全球萊姆病診斷市場魅力分析:各終端用戶

第9章 全球萊姆病診斷市場分析:各地區

  • 全球萊姆病診斷市場方案:各地區/國家
  • 全球萊姆病診斷市場金額佔有率、魅力分析:各地區
  • 全球萊姆病診斷市場預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲

第10章 北美的萊姆病診斷市場分析

第11章 歐洲的萊姆病診斷市場分析

第12章 亞太地區的萊姆病診斷市場分析

第13章 南美的萊姆病診斷市場分析

第14章 中東、非洲的萊姆病診斷市場分析

第15章 競爭情形

  • 競爭矩陣
  • 企業簡介
    • T2 Biosystems, Inc.
    • QIAGEN
    • DiaSorin SpA
    • Bio-Rad Laboratories
    • Thermo Fisher Scientific, Inc.
    • Trinity Biotech plc
    • IGeneX, Inc.
    • Lyme Diagnostics Ltd.
    • PerkinElmer, Inc.
    • Oxford Immunotec plc (Boulder Diagnostics)
    • Cenogenics Corporation
    • Quest Diagnostics
    • Ceres Nanosciences, Inc.
    • Galaxy Diagnostics
目錄
Product Code: TMRGL1658

Scope of the Report

TMR's report on the global Lyme disease diagnostic market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global Lyme disease diagnostic market for the period of 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Lyme disease diagnostic market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Lyme disease diagnostic market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the Lyme disease diagnostic market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global Lyme disease diagnostic market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Lyme disease diagnostic market.

The report delves into the competitive landscape of the global Lyme disease diagnostic market. Key players operating in the global Lyme disease diagnostic market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Lyme disease diagnostic market profiled in this report.

Key Questions Answered:

  • What is the sales/revenue generated by Lyme disease diagnostics across all regions during the forecast period?
  • What are the opportunities in the global Lyme disease diagnostic market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which diagnostic test segment is expected to generate the highest revenue globally in 2031? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Research Objectives and Research Approach

The comprehensive report on the global Lyme disease diagnostic market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller one. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Lyme disease diagnostic market in terms of diagnostic test, sample, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Lyme disease diagnostic market.

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions and Acronyms Used
  • 2.2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Key Industry Developments
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunity
  • 4.4. Global Lyme Disease Diagnostics Market Forecast
  • 4.5. Global Lyme Disease Diagnostics Market Outlook

5. Market Outlook

  • 5.1. Lyme Disease Epidemiology
  • 5.2. Regulations Related to Lyme Disease
  • 5.3. COVID-19 Pandemic Impact on Lyme Disease Diagnostics Industry
  • 5.4. Key Industry Development

6. Global Lyme Disease Diagnostics Market Analysis, by Diagnostic Test

  • 6.1. Introduction
  • 6.2. Global Lyme Disease Diagnostics Market Value Share Analysis, by Diagnostic Test
  • 6.3. Global Lyme Disease Diagnostics Market Forecast, by Diagnostic Test
    • 6.3.1. Serological Test
      • 6.3.1.1. ELISA
      • 6.3.1.2. Western Blot
    • 6.3.2. Polymerase Chain Reaction (PCR) Testing
    • 6.3.3. Immunofluorescence (IFA)
    • 6.3.4. lymphocyte Transformation Test
    • 6.3.5. Urine Antigen Testing
    • 6.3.6. Others
  • 6.4. Global Lyme Disease Diagnostics Market Analysis, by Diagnostic Test
  • 6.5. Global Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test

7. Global Lyme Disease Diagnostics Market Analysis, by Sample

  • 7.1. Introduction
  • 7.2. Global Lyme Disease Diagnostics Market Value Share Analysis, by Sample
  • 7.3. Global Lyme Disease Diagnostics Market Forecast, by Sample
    • 7.3.1. Blood
    • 7.3.2. Cerebrospinal Fluid (CSF)
    • 7.3.3. Joint Fluid
    • 7.3.4. Urine
  • 7.4. Global Lyme Disease Diagnostics Market Analysis, by Sample
  • 7.5. Global Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample

8. Global Lyme Disease Diagnostics Market Analysis, by End-user

  • 8.1. Introduction
  • 8.2. Global Lyme Disease Diagnostics Market Value Share Analysis, by End-user
  • 8.3. Global Lyme Disease Diagnostics Market Forecast, by End-user
    • 8.3.1. Hospitals
    • 8.3.2. Clinical Laboratories
    • 8.3.3. Physician Clinics
    • 8.3.4. Others
  • 8.4. Global Lyme Disease Diagnostics Market Analysis, by End-user
  • 8.5. Global Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user

9. Global Lyme Disease Diagnostics Market Analysis, by Region

  • 9.1. Global Lyme Disease Diagnostics Market Scenario, by Region/Country
  • 9.2. Global Lyme Disease Diagnostics Market Value Share and Attractiveness Analysis, by Region
  • 9.3. Global Lyme Disease Diagnostics Market Forecast, by Region
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East & Africa

10. North America Lyme Disease Diagnostics Market Analysis

  • 10.1. North America Lyme Disease Diagnostics Market Overview
  • 10.2. North America Lyme Disease Diagnostics Market Value Share Analysis, Diagnostic Test
  • 10.3. North America Lyme Disease Diagnostics Forecast, by Diagnostic Test
    • 10.3.1. Serological Test
      • 10.3.1.1. ELISA
      • 10.3.1.2. Western Blot
    • 10.3.2. Polymerase Chain Reaction (PCR) Testing
    • 10.3.3. Immunofluorescence (IFA)
    • 10.3.4. lymphocyte Transformation Test
    • 10.3.5. Urine Antigen Testing
    • 10.3.6. Others
  • 10.4. North America Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test
  • 10.5. North America Lyme Disease Diagnostics Market Analysis, by Sample
  • 10.6. North America Lyme Disease Diagnostics Market Forecast, by Sample
    • 10.6.1. Blood
    • 10.6.2. Cerebrospinal Fluid (CSF)
    • 10.6.3. Joint Fluid
    • 10.6.4. Urine
    • 10.6.5. Others
  • 10.7. North America Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample
  • 10.8. North America Lyme Disease Diagnostics Market Analysis, by End-user
  • 10.9. North America Lyme Disease Diagnostics Market Forecast, by End-user
    • 10.9.1. Hospitals
    • 10.9.2. Clinical Laboratories
    • 10.9.3. Physician Clinics
    • 10.9.4. Others
  • 10.10. North America Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user
  • 10.11. North America Lyme Disease Diagnostics Market Value Share and Attractiveness Analysis, by Country
  • 10.12. North America Lyme Disease Diagnostics Market Forecast, by Country
    • 10.12.1. U.S.
    • 10.12.2. Canada

11. Europe Lyme Disease Diagnostics Market Analysis

  • 11.1. Europe Lyme Disease Diagnostics Market Overview
  • 11.2. Europe Lyme Disease Diagnostics Market Value Share Analysis, Diagnostic Test
  • 11.3. Europe Lyme Disease Diagnostics Forecast, by Diagnostic Test
    • 11.3.1. Serological Test
      • 11.3.1.1. ELISA
      • 11.3.1.2. Western Blot
    • 11.3.2. Polymerase Chain Reaction (PCR) Testing
    • 11.3.3. Immunofluorescence (IFA)
    • 11.3.4. lymphocyte Transformation Test
    • 11.3.5. Urine Antigen Testing
    • 11.3.6. Others
  • 11.4. Europe Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test
  • 11.5. Europe Lyme Disease Diagnostics Market Analysis, by Sample
  • 11.6. Europe Lyme Disease Diagnostics Market Forecast, by Sample
    • 11.6.1. Blood
    • 11.6.2. Cerebrospinal Fluid (CSF)
    • 11.6.3. Joint Fluid
    • 11.6.4. Urine
  • 11.7. Europe Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample
  • 11.8. Europe Lyme Disease Diagnostics Market Analysis, by End-user
  • 11.9. Europe Lyme Disease Diagnostics Market Forecast, by End-user
    • 11.9.1. Hospitals
    • 11.9.2. Clinical Laboratories
    • 11.9.3. Physician Clinics
    • 11.9.4. Others
  • 11.10. Europe Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user
  • 11.11. Europe Lyme Disease Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 11.12. Europe Lyme Disease Diagnostics Market Forecast, by Country/Sub-region
    • 11.12.1. Germany
    • 11.12.2. France
    • 11.12.3. U.K.
    • 11.12.4. Italy
    • 11.12.5. Spain
    • 11.12.6. Rest of Europe

12. Asia Pacific Lyme Disease Diagnostics Market Analysis

  • 12.1. Asia Pacific Lyme Disease Diagnostics Market Overview
  • 12.2. Asia Pacific Lyme Disease Diagnostics Market Value Share Analysis, Diagnostic Test
  • 12.3. Asia Pacific Lyme Disease Diagnostics Forecast, by Diagnostic Test
    • 12.3.1. Serological Test
      • 12.3.1.1. ELISA
      • 12.3.1.2. Western Blot
    • 12.3.2. Polymerase Chain Reaction (PCR) Testing
    • 12.3.3. Immunofluorescence (IFA)
    • 12.3.4. lymphocyte Transformation Test
    • 12.3.5. Urine Antigen Testing
    • 12.3.6. Others
  • 12.4. Asia Pacific Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test
  • 12.5. Asia Pacific Lyme Disease Diagnostics Market Analysis, by Sample
  • 12.6. Asia Pacific Lyme Disease Diagnostics Market Forecast, by Sample
    • 12.6.1. Blood
    • 12.6.2. Cerebrospinal Fluid (CSF)
    • 12.6.3. Joint Fluid
    • 12.6.4. Urine
  • 12.7. Asia Pacific Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample
  • 12.8. Asia Pacific Lyme Disease Diagnostics Market Analysis, by End-user
  • 12.9. Asia Pacific Lyme Disease Diagnostics Market Forecast, by End-user
    • 12.9.1. Hospitals
    • 12.9.2. Clinical Laboratories
    • 12.9.3. Physician Clinics
    • 12.9.4. Others
  • 12.10. Asia Pacific Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user
  • 12.11. Asia Pacific Lyme Disease Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 12.12. Asia Pacific Lyme Disease Diagnostics Market Forecast, by Country/Sub-region
    • 12.12.1. Japan
    • 12.12.2. China
    • 12.12.3. India
    • 12.12.4. Australia & New Zealand
    • 12.12.5. Rest of Asia Pacific

13. Latin America Lyme Disease Diagnostics Market Analysis

  • 13.1. Latin America Lyme Disease Diagnostics Market Overview
  • 13.2. Latin America Lyme Disease Diagnostics Market Value Share Analysis, Diagnostic Test
  • 13.3. Latin America Lyme Disease Diagnostics Forecast, by Diagnostic Test
    • 13.3.1. Serological Test
      • 13.3.1.1. Elisa
      • 13.3.1.2. Western Blot
    • 13.3.2. Polymerase Chain Reaction (PCR) Testing
    • 13.3.3. Immunofluorescence (IFA)
    • 13.3.4. lymphocyte Transformation Test
    • 13.3.5. Urine Antigen Testing
    • 13.3.6. Others
  • 13.4. Latin America Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test
  • 13.5. Latin America Lyme Disease Diagnostics Market Analysis, by Sample
  • 13.6. Latin America Lyme Disease Diagnostics Market Forecast, by Sample
    • 13.6.1. Blood
    • 13.6.2. Cerebrospinal Fluid (CSF)
    • 13.6.3. Joint Fluid
    • 13.6.4. Urine
  • 13.7. Latin America Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample
  • 13.8. Latin America Lyme Disease Diagnostics Market Analysis, by End-user
  • 13.9. Latin America Lyme Disease Diagnostics Market Forecast, by End-user
    • 13.9.1. Hospitals
    • 13.9.2. Clinical Laboratories
    • 13.9.3. Physician Clinics
    • 13.9.4. Others
  • 13.10. Latin America Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user
  • 13.11. Latin America Lyme Disease Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 13.12. Latin America Lyme Disease Diagnostics Market Forecast, by Country/Sub-region
    • 13.12.1. Brazil
    • 13.12.2. Mexico
    • 13.12.3. Rest of Latin America

14. Middle East & Africa Lyme Disease Diagnostics Market Analysis

  • 14.1. Middle East & Africa Lyme Disease Diagnostics Market Overview
  • 14.2. Middle East & Africa Lyme Disease Diagnostics Market Value Share Analysis, Diagnostic Test
  • 14.3. Middle East & Africa Lyme Disease Diagnostics Forecast, by Diagnostic Test
    • 14.3.1. Serological Test
      • 14.3.1.1. ELISA
      • 14.3.1.2. Western Blot
    • 14.3.2. Polymerase Chain Reaction (PCR) Testing
    • 14.3.3. Immunofluorescence (IFA)
    • 14.3.4. lymphocyte Transformation Test
    • 14.3.5. Urine Antigen Testing
    • 14.3.6. Others
  • 14.4. Middle East & Africa Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test
  • 14.5. Middle East & Africa Lyme Disease Diagnostics Market Analysis, by Sample
  • 14.6. Middle East & Africa Lyme Disease Diagnostics Market Forecast, by Sample
    • 14.6.1. Blood
    • 14.6.2. Cerebrospinal Fluid (CSF)
    • 14.6.3. Joint Fluid
    • 14.6.4. Urine
  • 14.7. Middle East & Africa Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample
  • 14.8. Middle East & Africa Lyme Disease Diagnostics Market Analysis, by End-user
  • 14.9. Middle East & Africa Lyme Disease Diagnostics Market Forecast, by End-user
    • 14.9.1. Hospitals
    • 14.9.2. Clinical Laboratories
    • 14.9.3. Physician Clinics
    • 14.9.4. Others
  • 14.10. Middle East & Africa Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user
  • 14.11. Middle East & Africa Lyme Disease Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 14.12. Middle East & Africa Lyme Disease Diagnostics Market Forecast, by Country/Sub-region
    • 14.12.1. GCC Countries
    • 14.12.2. South Africa
    • 14.12.3. Rest of Middle East & Africa

15. Competition Landscape

  • 15.1. Competition Matrix
  • 15.2. Company Profiles
    • 15.2.1. T2 Biosystems, Inc.
      • 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.1.2. Financial Overview
      • 15.2.1.3. Product Portfolio
      • 15.2.1.4. SWOT Analysis
      • 15.2.1.5. Strategic Overview
    • 15.2.2. QIAGEN
      • 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.2.2. Product Portfolio
      • 15.2.2.3. SWOT Analysis
      • 15.2.2.4. Strategic Overview
    • 15.2.3. DiaSorin S.p.A.
      • 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.3.2. Product Portfolio
      • 15.2.3.3. SWOT Analysis
      • 15.2.3.4. Strategic Overview
    • 15.2.4. Bio-Rad Laboratories
      • 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.4.2. Product Portfolio
      • 15.2.4.3. SWOT Analysis
      • 15.2.4.4. Strategic Overview
    • 15.2.5. Thermo Fisher Scientific, Inc.
      • 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.5.2. Financial Overview
      • 15.2.5.3. Product Portfolio
      • 15.2.5.4. SWOT Analysis
      • 15.2.5.5. Strategic Overview
    • 15.2.6. Trinity Biotech plc
      • 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.6.2. Product Portfolio
      • 15.2.6.3. SWOT Analysis
      • 15.2.6.4. Strategic Overview
    • 15.2.7. IGeneX, Inc.
      • 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.7.2. Product Portfolio
      • 15.2.7.3. SWOT Analysis
      • 15.2.7.4. Strategic Overview
    • 15.2.8. Lyme Diagnostics Ltd.
      • 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.8.2. Product Portfolio
      • 15.2.8.3. SWOT Analysis
      • 15.2.8.4. Strategic Overview
    • 15.2.9. PerkinElmer, Inc.
      • 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.9.2. Product Portfolio
      • 15.2.9.3. SWOT Analysis
      • 15.2.9.4. Strategic Overview
    • 15.2.10. Oxford Immunotec plc (Boulder Diagnostics)
      • 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.10.2. Product Portfolio
      • 15.2.10.3. SWOT Analysis
      • 15.2.10.4. Strategic Overview
    • 15.2.11. Cenogenics Corporation
      • 15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.11.2. Product Portfolio
      • 15.2.11.3. SWOT Analysis
      • 15.2.11.4. Strategic Overview
    • 15.2.12. Quest Diagnostics
      • 15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.12.2. Product Portfolio
      • 15.2.12.3. SWOT Analysis
      • 15.2.12.4. Strategic Overview
    • 15.2.13. Ceres Nanosciences, Inc.
      • 15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.13.2. Product Portfolio
      • 15.2.13.3. SWOT Analysis
      • 15.2.13.4. Strategic Overview
    • 15.2.14. Galaxy Diagnostics
      • 15.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.14.2. Product Portfolio
      • 15.2.14.3. SWOT Analysis
      • 15.2.14.4. Strategic Overview

List of Tables

  • Table 01: Global Lyme Disease Diagnostics Market
  • Table 02: 2019A Total Revenue
  • Table 03: 2031F Total Revenue
  • Table 04: Executive Summary
  • Table 05: Market Overview
  • Table 06: Key Industry Events
  • Table 07: Impact of COVID-19 Pandemic
  • Table 08: Global Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 09: Global Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Serological Test, 2017-2031
  • Table 10: Global Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 11: Global Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 12: Global Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Region , 2017-2031
  • Table 13: North America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 14: North America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Serological Test, 2017-2031
  • Table 15: North America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 16: North America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: North America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 18: Europe Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 19: Europe Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Serological Test, 2018
  • Table 20: Europe Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 21: Europe Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 22: Europe Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-segment, 2017-2031
  • Table 23: Asia Pacific Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 24: Asia Pacific Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Serological Test, 2017-2031
  • Table 25: Asia Pacific Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 26: Asia Pacific Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 27: Asia Pacific Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-segment, 2017-2031
  • Table 28: Latin America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 29: Latin America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Serological Test, 2017-2031
  • Table 30: Latin America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 31: Latin America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 32: Latin America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 33: Middle East & Africa Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 34: Middle East & Africa Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Serological Test, 2017-2031
  • Table 35: Middle East & Africa Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 36: Middle East & Africa Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 37: Middle East & Africa Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-segment, 2017-2031
  • Table 38: T2 Biosystems, Inc.: Business Overview
  • Table 39: T2 Biosystems, Inc.: Strategic Overview
  • Table 40: QIAGEN.: Business Overview
  • Table 41: QIAGEN.: Strategic Overview
  • Table 42: DiaSorin S.p.A.: Business Overview
  • Table 43: DiaSorin S.p.A.: Strategic Overview
  • Table 44: Bio-Rad Laboratories: Business Overview
  • Table 45: Bio-Rad Laboratories: Strategic Overview
  • Table 46: Thermo Fisher Scientific, Inc.: Business Overview
  • Table 47: Thermo Fisher Scientific, Inc.: Strategic Overview
  • Table 48: Trinity Biotech plc: Business Overview
  • Table 49: Trinity Biotech plc: Strategic Overview
  • Table 50: Trinity Biotech plc: Business Overview
  • Table 51: Trinity Biotech plc: Strategic Overview
  • Table 52: IGeneX, Inc.: Business Overview
  • Table 53: IGeneX, Inc.: Strategic Overview
  • Table 54: Lyme Diagnostics Ltd.: Business Overview
  • Table 55: Lyme Diagnostics Ltd.: Strategic Overview
  • Table 56: PerkinElmer, Inc.: Business Overview
  • Table 57: PerkinElmer, Inc.: Strategic Overview
  • Table 58: Oxford Immunotec plc (Boulder Diagnostics): Business Overview
  • Table 59: Oxford Immunotec plc (Boulder Diagnostics): Strategic Overview
  • Table 60: Cenogenics Corporation: Business Overview
  • Table 61: Cenogenics Corporation: Strategic Overview
  • Table 62: Quest Diagnostics.: Business Overview
  • Table 63: Quest Diagnostics.: Strategic Overview
  • Table 64: Ceres Nanosciences, Inc.: Business Overview
  • Table 65: Ceres Nanosciences, Inc.: Strategic Overview
  • Table 66: Galaxy Diagnostics: Business Overview
  • Table 67: Galaxy Diagnostics: Strategic Overview

List of Figures

  • Figure 01: % CAGR (2021-2031)
  • Figure 02: Drivers
  • Figure 03: Global Lyme Disease Diagnostics Market - Drivers (1)
  • Figure 04: Global Lyme Disease Diagnostics Market - Drivers (2)
  • Figure 05: Restraints
  • Figure 06: Opportunities
  • Figure 07: Lyme Disease Epidemiology
  • Figure 08: COVID-19 Pandemics Short- / Mid- / Long-term Impact on Lyme Disease Diagnostics Market
  • Figure 09: Introduction-Global Lyme Disease Diagnostics Market, by Diagnostic Test
  • Figure 11: Global Lyme Disease Diagnostics Market Value Share Analysis, by Diagnostic Test, 2019 and 2031
  • Figure 12: Global Lyme Disease Diagnostics Market Value (US$ Mn), by Serological Test, 2017-2031
  • Figure 13: Global Lyme Disease Diagnostics Market Value (US$ Mn), by Polymerase Chain Reaction (PCR) Testing, 2017-2031
  • Figure 14: Global Lyme Disease Diagnostics Market Value (US$ Mn), by Immunofluorescence (IFA), 2017-2031
  • Figure 15: Global Lyme Disease Diagnostics Market Value (US$ Mn), by lymphocyte Transformation Test, 2017-2031
  • Figure 16: Global Lyme Disease Diagnostics Market Value (US$ Mn), by Urine Antigen Testing, 2017-2031
  • Figure 17: Global Lyme Disease Diagnostics Market Value (US$ Mn), by Others, 2017-2031
  • Figure 18: Global Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2021-2031
  • Figure 19: Introduction - Global Lyme Disease Diagnostics Market Analysis, by Sample (1/4)
  • Figure 20: Introduction - Global Lyme Disease Diagnostics Market Analysis, by Sample (2/4)
  • Figure 21: Introduction - Global Lyme Disease Diagnostics Market Analysis, by Sample (3/4)
  • Figure 22: Introduction - Global Lyme Disease Diagnostics Market Analysis, by Sample (4/4)
  • Figure 23: Global Lyme Disease Diagnostics Market Value Share Analysis, by Sample, 2019 and 2031
  • Figure 24: Global Lyme Disease Diagnostics Market Value (US$ Mn), by Blood, 2017-2031
  • Figure 25: Global Lyme Disease Diagnostics Market Value (US$ Mn), by Cerebrospinal Fluid (CSF), 2017-2031
  • Figure 26: Global Lyme Disease Diagnostics Market Value (US$ Mn), by Joint Fluid, 2017-2031
  • Figure 27: Global Lyme Disease Diagnostics Market Value (US$ Mn), by Urine, 2017-2031
  • Figure 28: Introduction-Global Lyme Disease Diagnostics Market Analysis, by End-user (1/4)
  • Figure 29: Introduction-Global Lyme Disease Diagnostics Market Analysis, by End-user (2/4)
  • Figure 30: Introduction -Global Lyme Disease Diagnostics Market Analysis, by End-user (3/4)
  • Figure 31: Introduction -Global Lyme Disease Diagnostics Market Analysis, by End-user (4/4)
  • Figure 32: Global Lyme Disease Diagnostics Market Value Share Analysis, by End-user, 2019 and 2031
  • Figure 33: Global Lyme Disease Diagnostics Market Value (US$ Mn), by Hospitals, 2017-2031
  • Figure 34: Global Lyme Disease Diagnostics Market Value (US$ Mn), by Clinical Laboratories, 2017-2031
  • Figure 35: Global Lyme Disease Diagnostics Market Value (US$ Mn), by Physician Clinics, 2017-2031
  • Figure 36: Global Lyme Disease Diagnostics Market Value (US$ Mn), by Others, 2017-2031
  • Figure 37: North America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 38: North America Lyme Disease Diagnostics Market Value Share Analysis, by Diagnostic Test, 2019 and 2031
  • Figure 39: North America Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2021-2031
  • Figure 40: North America Lyme Disease Diagnostics Market Value Share Analysis, by Sample, 2019 and 2031
  • Figure 41: North America Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample, 2020
  • Figure 42: North America Lyme Disease Diagnostics Market Value Share Analysis, by End-user, 2020
  • Figure 43: North America Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2020
  • Figure 44: Europe Lyme Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 45: Europe Lyme Disease Diagnostics Market Value Share Analysis, by Diagnostic Test, 2019 and 2031
  • Figure 46: Europe Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2021-2031
  • Figure 47: Europe Lyme Disease Diagnostics Market Value Share Analysis, by Sample, 2019 and 2031
  • Figure 48: Europe Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample, 2020
  • Figure 49: Europe Lyme Disease Diagnostics Market Value Share Analysis, by End-user, 2020
  • Figure 50: Europe Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2020
  • Figure 51: Asia Pacific Lyme Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 52: Asia Pacific Lyme Disease Diagnostics Market Value Share Analysis, by Diagnostic Test, 2019 and 2031
  • Figure 53: Asia Pacific Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2021-2031
  • Figure 54: Asia Pacific Lyme Disease Diagnostics Market Value Share Analysis, by Sample, 2019 and 2031
  • Figure 55: Asia Pacific Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample, 2020
  • Figure 56: Asia Pacific Lyme Disease Diagnostics Market Value Share Analysis, by End-user, 2020
  • Figure 57: Asia Pacific Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2020
  • Figure 58: Latin America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 59: Latin America Lyme Disease Diagnostics Market Value Share Analysis, by Diagnostic Test, 2019 and 2031
  • Figure 60: Latin America Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2021-2031
  • Figure 61: Latin America Lyme Disease Diagnostics Market Value Share Analysis, by Sample, 2019 and 2031
  • Figure 62: Latin America Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample, 2020
  • Figure 63: Latin America Lyme Disease Diagnostics Market Value Share Analysis, by End-user, 2020
  • Figure 64: Latin America Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2020
  • Figure 65: Middle East & Africa Lyme Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 66: Middle East & Africa Lyme Disease Diagnostics Market Value Share Analysis, by Diagnostic Test, 2019 and 2031
  • Figure 67: Middle East & Africa Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2021-2031
  • Figure 68: Middle East & Africa Lyme Disease Diagnostics Market Value Share Analysis, by Sample, 2019 and 2031
  • Figure 69: Middle East & Africa Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample, 2020
  • Figure 70: Middle East & Africa Lyme Disease Diagnostics Market Value Share Analysis, by End-user, 2020